Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

BUY
$7.06 - $23.63 $500,554 - $1.68 Million
70,900 New
70,900 $593,000
Q2 2021

Aug 12, 2021

SELL
$27.43 - $32.7 $5.54 Million - $6.6 Million
-201,900 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$21.37 - $34.38 $43.9 Million - $70.7 Million
-2,056,592 Reduced 91.06%
201,900 $6.41 Million
Q4 2020

Feb 16, 2021

SELL
$15.31 - $21.12 $21 Million - $29 Million
-1,372,602 Reduced 37.8%
2,258,492 $46.9 Million
Q3 2020

Nov 12, 2020

SELL
$14.88 - $20.13 $26.2 Million - $35.5 Million
-1,762,793 Reduced 32.68%
3,631,094 $56.4 Million
Q2 2020

Aug 13, 2020

BUY
$13.31 - $20.51 $11 Million - $17 Million
828,450 Added 18.15%
5,393,887 $98.7 Million
Q1 2020

May 13, 2020

SELL
$12.98 - $30.25 $1 Million - $2.34 Million
-77,334 Reduced 1.67%
4,565,437 $70.8 Million
Q4 2019

Feb 12, 2020

SELL
$18.89 - $31.89 $23.6 Million - $39.8 Million
-1,248,539 Reduced 21.19%
4,642,771 $139 Million
Q3 2019

Nov 13, 2019

SELL
$20.88 - $25.66 $8.56 Million - $10.5 Million
-409,895 Reduced 6.51%
5,891,310 $129 Million
Q2 2019

Aug 07, 2019

SELL
$20.52 - $26.45 $18.6 Million - $24 Million
-908,013 Reduced 12.6%
6,301,205 $159 Million
Q1 2019

May 08, 2019

SELL
$20.23 - $26.29 $25.2 Million - $32.7 Million
-1,243,446 Reduced 14.71%
7,209,218 $178 Million
Q4 2018

Feb 12, 2019

BUY
$17.64 - $28.32 $1.33 Million - $2.13 Million
75,175 Added 0.9%
8,452,664 $156 Million
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $173 Million - $215 Million
8,377,489 New
8,377,489 $215 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.